Related Experiment Video
Updated: Jun 4, 2026

The Use of Pharmacological-challenge fMRI in Pre-clinical Research: Application to the 5-HT System
Published on: April 25, 2012
5-HT(6) receptor and cognition.
Xabier Codony1, Jose Miguel Vela, Maria Javier Ramírez
1Laboratorios Dr Esteve SA, Barcelona, Spain.
Serotonin 5-HT(6) receptor antagonists and agonists show promise for treating cognitive dysfunction. Research explores these compounds
Area of Science:
- Neuroscience
- Pharmacology
Background:
- The serotonin 5-HT(6) receptor is a target for cognitive dysfunction.
- Selective antagonists have been developed since 1993.
- Recent studies also highlight agonists' potential.
Purpose of the Study:
- To review preclinical and clinical evidence for 5-HT(6) receptor compounds in cognition.
- To explore the biochemical and neurochemical mechanisms of action.
Main Methods:
- Review of preclinical studies in animal models.
- Review of clinical trial data, including Phase II for SB-742457.
- Analysis of proposed molecular mechanisms.
Main Results:
- Both 5-HT(6) receptor antagonists and agonists improve learning and memory in animal models.
- One antagonist, SB-742457, has advanced to Phase II trials for Alzheimer's disease.
- Evidence suggests specific biochemical pathways are involved.
Conclusions:
- 5-HT(6) receptor modulation represents a promising therapeutic strategy for cognitive disorders.
- Further research into agonists and antagonists is warranted.
- Understanding the mechanisms can optimize treatment development.
Related Concept Videos
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
G-protein Coupled Receptors
Role of Neurotransmitters in Memory
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is critical for...
Drugs Affecting Neurotransmitter Release or Uptake
Role of Cerebellum and Prefrontal Cortex in Memory
